FDA Inspection
Aurobindo Pharma LtdFDA Inspection 1010385 - Aurobindo Pharma Ltd - April 18, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Aurobindo Pharma Ltd, with an inspection on April 18, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · 83bc7209-2966-4c8d-84a1-86ccb14266cc
Violation Codes6
21 CFR 211.160(a)21 CFR 211.160(b)21 CFR 211.165(e)21 CFR 211.194(a)21 CFR 211.22(a)21 CFR 211.22(d)
Full citation text and observation details available on the Dashboard.